The Moving Average Convergence Divergence (MACD) for ATR turned positive on October 14, 2026. Looking at past instances where ATR's MACD turned positive, the stock continued to rise in 33 of 58 cases over the following month. The odds of a continued upward trend are 57%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on ATR as a result. In 41 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 50%.
ATR moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATR advanced for three days, in 181 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
ATR broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ATR entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 41 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 53 (best 1 - 100 worst), indicating fairly steady price growth. ATR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.039) is normal, around the industry mean (4.961). P/E Ratio (22.434) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (2.595) is also within normal values, averaging (4.143). Dividend Yield (0.015) settles around the average of (0.005) among similar stocks. P/S Ratio (2.072) is also within normal values, averaging (56.876).
The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
SYK moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 24 of 42 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 57%.
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on SYK as a result. In 48 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.
The Moving Average Convergence Divergence (MACD) for SYK just turned positive on September 28, 2026. Looking at past instances where SYK's MACD turned positive, the stock continued to rise in 23 of 44 cases over the following month. The odds of a continued upward trend are 52%.
Following a +3.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where SYK advanced for three days, in 171 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
SYK broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SYK entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. SYK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.759) is normal, around the industry mean (2.874). P/E Ratio (30.586) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (1.289) is also within normal values, averaging (11.052). Dividend Yield (0.012) settles around the average of (0.009) among similar stocks. P/S Ratio (4.259) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 76 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SYK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
ATR | SYK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 29 | 37 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 72 Overvalued | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 82 | 76 | |
SMR RATING 1..100 | 59 | 52 | |
PRICE GROWTH RATING 1..100 | 53 | 56 | |
P/E GROWTH RATING 1..100 | 41 | 83 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ATR's Valuation (72) in the Containers Or Packaging industry is in the same range as SYK (76) in the Medical Specialties industry. This means that ATR’s stock grew similarly to SYK’s over the last 12 months.
SYK's Profit vs Risk Rating (76) in the Medical Specialties industry is in the same range as ATR (82) in the Containers Or Packaging industry. This means that SYK’s stock grew similarly to ATR’s over the last 12 months.
SYK's SMR Rating (52) in the Medical Specialties industry is in the same range as ATR (59) in the Containers Or Packaging industry. This means that SYK’s stock grew similarly to ATR’s over the last 12 months.
ATR's Price Growth Rating (53) in the Containers Or Packaging industry is in the same range as SYK (56) in the Medical Specialties industry. This means that ATR’s stock grew similarly to SYK’s over the last 12 months.
ATR's P/E Growth Rating (41) in the Containers Or Packaging industry is somewhat better than the same rating for SYK (83) in the Medical Specialties industry. This means that ATR’s stock grew somewhat faster than SYK’s over the last 12 months.
| ATR | SYK | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 42% | 1 day ago 58% |
| Stochastic ODDS (%) | 1 day ago 52% | 1 day ago 50% |
| Momentum ODDS (%) | 1 day ago 50% | 1 day ago 53% |
| MACD ODDS (%) | 1 day ago 57% | 1 day ago 52% |
| TrendWeek ODDS (%) | 1 day ago 53% | 1 day ago 56% |
| TrendMonth ODDS (%) | 1 day ago 52% | 1 day ago 50% |
| Advances ODDS (%) | 3 days ago 54% | 3 days ago 56% |
| Declines ODDS (%) | 11 days ago 51% | 9 days ago 52% |
| BollingerBands ODDS (%) | 1 day ago 46% | 1 day ago 70% |
| Aroon ODDS (%) | 1 day ago 61% | 1 day ago 45% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ATR’s FA Score shows that 0 FA rating(s) are green while SYK’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ATR’s TA Score shows that 4 TA indicator(s) are bullish while SYK’s TA Score has 4 bullish TA indicator(s).
ATR (@Pharmaceuticals: Other) experienced а +4.46% price change this week, while SYK (@Medical/Nursing Services) price change was +5.67% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
ATR is expected to report earnings on Oct 29, 2026.
SYK is expected to report earnings on Oct 29, 2026.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, ATR has been loosely correlated with SYK. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ATR jumps, then SYK could also see price increases.
A.I.dvisor indicates that over the last year, SYK has been loosely correlated with ISRG. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then ISRG could also see price increases.